October 1, 2006European Heart Journal Supplements
Premature withdrawal and alternative therapies to dual oral antiplatelet therapy
Key result
Premature interruption of dual oral antiplatelet therapy increases the risk of recurrent ischemic events, highlighting an urgent need for evidence-based peri-operative management strategies.
Population
Patients eligible for temporary dual oral antiplatelet therapy due to recent drug-eluting stent implantation…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports avoiding premature DAPT interruption where feasible; leaves open optimal peri-operative protocols pending prospective trials.
Structured PICO
P
Population
Patients eligible for temporary dual oral antiplatelet therapy due to recent drug-eluting stent implantation or recent acute coronary syndrome
E
Exposure
Premature interruption of dual oral antiplatelet therapy and potential alternative therapies
Premature interruption of dual oral antiplatelet therapy in high-risk patients can lead to recurrent ischemic events, highlighting the urgent need for evidence-based peri-operative management strategies.
Cite This Study
Collet et al. (2006) conducted a review in Patients on dual oral antiplatelet therapy. Premature withdrawal of dual oral antiplatelet therapy was evaluated. Premature interruption of dual oral antiplatelet therapy increases the risk of recurrent ischemic events, highlighting an urgent need for evidence-based peri-operative management strategies.